Providing the right stakeholders with unobstructed access to sensitive data is essential in any industry. Within the pharmaceutical and biotech industries, inefficient data sharing and collaboration slow down the research process and delay the launch of new products.

However implementing an effective data share approach can be extremely complex through a combination of business, security, privacy and regulatory concerns. It involves not only providing secure access to the data sets that an end user is entitled to view, but also limiting access to specific pieces of information within the data sets.